These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8794793)

  • 1. A simple filter-paper technique allows detection of mucosal cytokine levels in vivo in ulcerative colitis. Interleukin-1 and interleukin-1-receptor antagonist.
    Hendel J; Nielsen OH; Madsen S; Brynskov J
    Dig Dis Sci; 1996 Sep; 41(9):1775-9. PubMed ID: 8794793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalance of the interleukin 1 system in colonic mucosa--association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2.
    Andus T; Daig R; Vogl D; Aschenbrenner E; Lock G; Hollerbach S; Köllinger M; Schölmerich J; Gross V
    Gut; 1997 Nov; 41(5):651-7. PubMed ID: 9414973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of interleukin-10 on the interleukin-1 receptor antagonist/interleukin-1 beta ratio in the colonic mucosa of ulcerative colitis.
    Ishizuka K; Sugimura K; Homma T; Matsuzawa J; Mochizuki T; Kobayashi M; Suzuki K; Otsuka K; Tashiro K; Yamaguchi O; Asakura H
    Digestion; 2001; 63 Suppl 1():22-7. PubMed ID: 11173905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: cytokine profiles and endoscopic findings.
    Yamamoto T; Saniabadi AR; Umegae S; Matsumoto K
    Inflamm Bowel Dis; 2006 Aug; 12(8):719-26. PubMed ID: 16917227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease.
    Ludwiczek O; Vannier E; Borggraefe I; Kaser A; Siegmund B; Dinarello CA; Tilg H
    Clin Exp Immunol; 2004 Nov; 138(2):323-9. PubMed ID: 15498044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper.
    Carty E; De Brabander M; Feakins RM; Rampton DS
    Gut; 2000 Apr; 46(4):487-92. PubMed ID: 10716677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional interactions between mucosal IL-1, IL-ra and TGF-beta 1 in ulcerative colitis.
    Ashwood P; Harvey R; Verjee T; Wolstencroft R; Thompson RP; Powell JJ
    Inflamm Res; 2004 Feb; 53(2):53-9. PubMed ID: 15021969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonic mucosal interleukin 1 receptor antagonist in inflammatory bowel disease.
    Nishiyama T; Mitsuyama K; Toyonaga A; Sasaki E; Tanikawa K
    Digestion; 1994; 55(6):368-73. PubMed ID: 7705549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of cytokine release from colonic explants by bacterial antigens in inflammatory bowel disease.
    Dionne S; Laberge S; Deslandres C; Seidman EG
    Clin Exp Immunol; 2003 Jul; 133(1):108-14. PubMed ID: 12823284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease.
    Stokkers PC; van Aken BE; Basoski N; Reitsma PH; Tytgat GN; van Deventer SJ
    Gut; 1998 Jul; 43(1):33-9. PubMed ID: 9771403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance and assessment of cytokines in various stages of ulcerative colitis.
    Zou K; Liu S; Xie X; Yi C
    J Tongji Med Univ; 2001; 21(4):308-9. PubMed ID: 12539555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.
    Casini-Raggi V; Kam L; Chong YJ; Fiocchi C; Pizarro TT; Cominelli F
    J Immunol; 1995 Mar; 154(5):2434-40. PubMed ID: 7868909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of circulating interleukin-1 receptor antagonist expression in children with inflammatory bowel disease.
    Hyams JS; Fitzgerald JE; Wyzga N; Treem WR; Justinich CJ; Kreutzer DL
    Dig Dis Sci; 1994 Sep; 39(9):1893-9. PubMed ID: 8082495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of moxibustion with different duration on colonic epithelial structure, serum inflammatory cytokines, and intestinal mucosa inflammatory cell signal transduction pathways].
    Ma TM; Han Y; Ma XD; Zeng XX; Ge W
    Zhen Ci Yan Jiu; 2014 Feb; 39(1):20-6. PubMed ID: 24684107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis.
    Carter MJ; Jones S; Camp NJ; Cox A; Mee J; Warren B; Duff GW; Lobo AJ; di Giovine FS
    Genes Immun; 2004 Jan; 5(1):8-15. PubMed ID: 14735144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis.
    Tsukada Y; Nakamura T; Iimura M; Iizuka BE; Hayashi N
    Am J Gastroenterol; 2002 Nov; 97(11):2820-8. PubMed ID: 12425554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut lavage IgG and interleukin 1 receptor antagonist:interleukin 1 beta ratio as markers of intestinal inflammation in children with inflammatory bowel disease.
    Troncone R; Caputo N; Campanozzi A; Cucciardi M; Esposito V; Russo R; De Vizia B; Greco L; Cucchiara S
    Gut; 1997 Jul; 41(1):60-5. PubMed ID: 9274473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fish oil enriched enteral diet on inflammatory bowel disease tissues in organ culture: differential effects on ulcerative colitis and Crohn's disease.
    Meister D; Ghosh S
    World J Gastroenterol; 2005 Dec; 11(47):7466-72. PubMed ID: 16437718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
    van Bommel EF; Hesse CJ; Jutte NH; Zietse R; Bruining HA; Weimar W
    Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
    Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
    Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.